Par Drugs and Chemicals Limited — Board Meeting, 07-08-2025: Outcome of Board Meeting

PAR DRUGS AND CHEMICALS: The board has announced a meeting outcome, approving the financial results for the quarter ended June 30, 2025. Revenue from operations stood at ₹26.05 Cr, with total revenue at ₹27.88 Cr. Profit for the period was ₹3.33 Cr, and EPS at ₹2.70. The results are standalone, as the company has no subsidiaries. Additionally, the existing banking facility limit of ₹1.61 Cr with Kotak Mahindra Bank was renewed without revision. The trading window for insiders will open 48 hours after the results declaration.